COVID-19, Arrhythmic Risk, and Inflammation
- 7 July 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 142 (1), 7-9
- https://doi.org/10.1161/circulationaha.120.047293
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 PandemicJournal of the American College of Cardiology, 2020
- Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathiesNature Reviews Immunology, 2018
- Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointesHeart, 2017
- Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritisEuropean Heart Journal, 2016
- Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic InflammationArthritis Care & Research, 2014